Jardiance 25 mg Tablet contains Empagliflozin, categorized as an anti-diabetic drug. It is utilized for the management of type 2 diabetes in adults when diet and exercise alone are insufficient. Additionally, it aids in reducing the risk of heart disease in individuals with type 2 diabetes and is employed in the treatment of heart failure in adults with weakened heart pumping function.

• Used when diet and exercise are inadequate in controlling blood glucose levels.
• Symptoms of diabetes include increased thirst, urination, hunger, blurry vision, numbness in extremities, and fatigue.
• Assists in lowering the risk of heart disease associated with type 2 diabetes mellitus.
• Employed in adults with heart failure and reduced ejection fraction to enhance cardiac function.
• Inform your doctor about serious liver, kidney, or heart issues, or if you have diabetes type 1.
• Not recommended for pregnant or breastfeeding women. Consult your doctor before usage.
• Not recommended for children and adolescents below 18 years of age.
• Elderly patients (above 75 years) should consult their doctor due to limited therapeutic experience.

Before starting Jardiance 25 mg Tablet, undergo necessary blood tests as recommended by your doctor. Adhere to dietary and exercise advice provided. Keep your doctor informed about your health condition for optimal diabetes and heart management.